Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: Co-localization of CD8⁺ T cells with JCV-infected glial cells

References

• Aksamit A J, Gendelman H E, Orenstein J M, Pezeshkpour G H. AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry. Neurology 1990; 40: 1073–1078, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Antinori A, Cingolani A, Lorenzini P, Giancola M L, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono M I, Fibbia G C, Mena M, Finazzi M G, Guaraldi G, Ammassari A, d'Arminio Monforte A, Cinque P, De Luca A. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003; 9(Suppl 1)47–53, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Astrom K E, Mancall E L, Richardson E P. Progressive multifocal leukoencephalopathy. Brain 1958; 81: 93–127, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Berger J R, Koralnik I J. Progressive Multifocal Leukoencephalopathy and Natalizumab—Unforeseen Consequences. N Engl J Med 2005; 353: 414–416, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Berger J R, Levy R M, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998; 44: 341–349, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Drazen J M. Patients at Risk. N Engl J Med 2005; 353: 417, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Du Pasquier R A, Kuroda M J, Schmitz J E, Zheng Y, Martin K, Peyerl F W, Lifton M, Gorgone D, Autissier P, Letvin N L, Koralnik I J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol 2003; 77: 11918–11926, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Du Pasquier R A, Kuroda M J, Zheng Y, Jean-Jacques J, Letvin N L, Koralnik I J. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004; 127: 1970–1978, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Katz-Brull R, Lenkinski R E, Du Pasquier R A, Koralnik I J. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004; 63: 897–900, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kim W K, Corey S, Chesney G, Knight H, Klumpp S, Wuthrich C, Letvin N, Koralnik I, Lackner A, Veasey R, Williams K. Identification of T lymphocytes in simian immunodeficiency virus encephalitis: Distribution of CD8+ T cells in association with central nervous system vessels and virus. J Neurovirol 2004; 10: 315–325, [INFOTRIEVE], [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Kleinschmidt-Demasters B K, Tyler K L. Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis. N Engl J Med 2005; 353: 369–374, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koralnik I J, Du Pasquier R A, Kuroda M J, Schmitz J E, Dang X, Zheng Y, Lifton M, Letvin N L. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 2002; 168: 499–504, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Koralnik I J, Du Pasquier R A, Letvin N L. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 2001; 75: 3483–3487, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koralnik I J, Schellingerhout D, Frosch M P. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med 2004; 350: 1882–1893, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Langer-Gould A, Atlas S W, Bollen A W, Pelletier D. Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab. N Engl J Med 2005; 353: 375–381, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Morgello S, Gelman B B, Kozlowski P B, Vinters H V, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer E J. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 2001; 27: 326–335, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Padgett B L, Walker D L, ZuRhein G M, Eckroade R J, Dessel B H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257–1260, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Richardson E P, Jr., Johnson P C. Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol Suppl (Berl) 1975; 247–250, Suppl[CSA]
   Google Scholar
• Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease. N Engl J Med 2005; 353: 362–368, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vendrely A, Bienvenu B, Gasnault J, Thiebault J B, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 2005; 109: 449–455, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945; 1: 80–83, [CSA]
   Web of Science ®Google Scholar